Clinical trial
LUNG-05: Investigating Chemotherapy Effectiveness for NSCLC Metastatic Patients
NCT06576635 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LUNG-05: Investigating Chemotherapy Effectiveness for NSCLC Metastatic Patients
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 16, 2024
- Completion date
- September 30, 2026
- Enrollment
- 29 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nsclc